Comparing as AI Medical Imaging & DiagnosticsViz.ai vs Aidoc
Core Differences
The fundamental difference between Viz.ai and Aidoc lies in their primary focus and architectural emphasis within the medical AI landscape.
- Viz.ai is designed as an AI-powered care coordination and workflow optimization platform. While it performs real-time AI analysis of imaging, its core value proposition is the simultaneous alerting and coordination of the entire care team (ED, neurologist, interventionalist, transfer team) to rapidly respond to detected acute conditions like LVO stroke, PE, and aortic dissection. It acts as a digital orchestrator, ensuring critical information reaches the right specialists immediately to reduce treatment delays. Its architecture is geared towards facilitating rapid, integrated clinical pathways for a specific set of time-sensitive diseases.
- Aidoc, on the other hand, is a more broad-spectrum clinical AI platform for radiology triage. Its aiOS platform provides a unified infrastructure for detecting a much wider array of acute conditions across various imaging modalities (CT, MRI, X-ray, echo). While it also includes automated care team alerts, its emphasis is on providing a comprehensive AI layer for the radiology department to triage cases, prioritize urgent findings, and integrate with existing PACS/EHR systems. Aidoc's CARE1 foundation model and BRIDGE framework suggest an architectural focus on scalable, multimodal AI deployment across the entire imaging workflow, extending beyond just acute care coordination to potentially include population health tools and operational analytics.
Verdict by Category
Best for Acute Stroke/PE Workflow
Viz.ai boasts a peer-reviewed 44% reduction in DIDO times for LVO stroke patients, highlighting its deep workflow integration for these critical conditions.
Broadest AI Portfolio (Conditions)
Aidoc offers dozens of FDA-cleared algorithms covering a wider array of acute conditions beyond stroke, PE, and aortic disease, including fractures, nodules, and cardiac issues.
Most Widely Adopted
Aidoc is deployed in nearly 2,000 hospitals globally, making it the most widely adopted AI radiology platform compared to Viz.ai's 1,000+ deployments.
Care Coordination Focus
Viz.ai's platform is specifically designed for simultaneous mobile alerts to the *entire care team*, emphasizing collaborative workflow and eliminating communication delays.
Foundation Model / Future Tech
Aidoc's CARE1 foundation model and BRIDGE framework with NVIDIA represent a more advanced, scalable approach to enterprise AI deployment and multimodal data analysis.
Reimbursement Advantage
Viz.ai uniquely holds a Medicare New Technology Add-on Payment (NTAP) designation, providing hospitals with additional reimbursement for qualifying patient encounters.
Editor's Take
Honest opinion from our review team
As an editor evaluating the impact of these technologies, I found that both Viz.ai and Aidoc represent a monumental leap forward in acute care, fundamentally changing how hospitals respond to life-threatening conditions. Viz.ai, in particular, feels like a tightly engineered solution for specific emergency workflows. Its focus on orchestrating the entire care team for stroke and PE, with the promise of significantly reduced DIDO times, is incredibly compelling. The immediate, simultaneous alerts feel revolutionary compared to traditional phone-tag, offering a clear, tangible improvement in patient outcomes. It's less about a general AI tool and more about a precision instrument for critical care coordination. Aidoc, on the other hand, feels like a robust, foundational layer for the entire radiology department. Its extensive breadth of FDA clearances and the ambition of its CARE1 foundation model suggest a more encompassing vision for AI in medical imaging. While both are enterprise-focused, Viz.ai's targeted efficacy and unique reimbursement pathway make a strong case for its immediate, high-impact clinical adoption, especially in stroke centers. Aidoc's broader platform, however, hints at a more scalable and versatile future for AI across a wider spectrum of hospital imaging needs.
Detailed Comparison24 Criteria
Complete side-by-side breakdown of specifications, capabilities, and feature parity
Both Viz.ai and Aidoc operate exclusively on custom enterprise contracts with hospitals and health systems, meaning there is no published pricing or self-serve option for either platform. This model is typical for highly specialized, integrated medical AI solutions that require significant implementation and support.
- Viz.ai's pricing is negotiated based on factors like hospital type, imaging volume, the number of conditions covered, and multi-site deployment needs. A significant value proposition for Viz.ai is its Medicare New Technology Add-on Payment (NTAP) designation. This provides hospitals with an additional reimbursement of approximately $1,040 per qualifying patient encounter, which can partially offset the platform's cost and demonstrate a clear return on investment for stroke and PE patients. This unique reimbursement pathway is a strong financial incentive for hospitals considering Viz.ai.
- Aidoc's pricing is also customized based on hospital size, imaging volume, the number of AI algorithms deployed, and integration complexity. While Aidoc does not explicitly mention an NTAP-like reimbursement, its value proposition lies in its broader applicability across numerous acute conditions and its scalable aiOS platform that can serve as a unified AI infrastructure for an entire radiology department. This breadth can justify the investment by improving efficiency and outcomes across a wider range of cases and potentially reducing overall operational costs for radiology triage. Both require direct engagement with their sales teams for a tailored quote, reflecting the complex nature of integrating these critical systems into hospital workflows.
Viz.ai Pros & Cons
Pros
- 12 FDA-cleared algorithms — broadest acute-condition AI portfolio in its class
- Medicare NTAP reimbursement pathway — unique among AI imaging platforms
- 44% reduction in DIDO times for stroke patients — peer-reviewed clinical evidence (ISC 2026)
- 1,000+ hospital deployments across U.S. and Europe
- Backed by Google Ventures, Kleiner Perkins, and Tiger Global — $289M raised
- Simultaneous mobile alerts to full care team — no phone-tag delays
- Expands from neurology to cardiology and pulmonology in one unified platform
Cons
- Enterprise-only pricing — no self-serve or small clinic access
- No published pricing — all contracts are custom
- Primarily focused on acute/time-sensitive conditions — not general radiology reads
- Requires integration with existing hospital imaging infrastructure
- Implementation and onboarding take time for large multi-site systems
Aidoc Pros & Cons
Pros
- Deployed in nearly 2,000 hospitals — the most widely adopted AI radiology platform globally
- 60M+ patient cases analyzed annually — proven at massive scale
- $534M raised — one of the best-funded medical AI companies in the world
- Dozens of FDA clearances — most extensively cleared AI imaging portfolio available
- PACS-agnostic — works with any existing radiology infrastructure
- Gartner Cool Vendor and named in multiple industry AI leadership reports
- CARE1 foundation model and BRIDGE/NVIDIA framework for next-gen AI deployment
Cons
- Enterprise-only — not available for small clinics or independent radiologists
- No published pricing — requires sales engagement for quotes
- Requires integration with existing PACS and EHR infrastructure
- Deployment and onboarding can take weeks to months for large systems
- AI recommendations still require radiologist review and sign-off
AI Verdict
In the rapidly evolving landscape of medical AI, Viz.ai and Aidoc stand out as pioneering forces, each transforming acute care with FDA-cleared algorithms. While both platforms leverage artificial intelligence to detect time-sensitive medical conditions from imaging scans, their core philosophies and strategic emphasis present distinct advantages. Viz.ai is fundamentally an AI care coordination platform primarily focused on optimizing workflows and reducing time-to-treatment for specific, high-acuity conditions like stroke, pulmonary embolism, and aortic disease. Its strength lies in its ability to analyze CT scans in real-time and simultaneously alert the entire care team via a HIPAA-compliant mobile app, effectively eliminating communication delays that are critical in conditions where every minute counts. This targeted, workflow-centric approach has demonstrably led to a 44% reduction in door-in-door-out (DIDO) times for LVO stroke patients, backed by robust clinical evidence and a unique Medicare NTAP reimbursement pathway. Ideal for health systems prioritizing rapid response and integrated care pathways for these specific conditions, Viz.ai acts as a digital orchestrator of emergency medical teams.
Conversely, Aidoc positions itself as a more comprehensive clinical AI platform for radiology triage, boasting one of the broadest portfolios of FDA clearances in the medical AI space. While also excelling in detecting acute conditions such as stroke, PE, and aortic dissection, Aidoc extends its reach to a wider array of findings including vertebral fractures, nodules, and cardiac conditions across multiple modalities (CT, MRI, X-ray, echo). Its aiOS platform, powered by the CARE1 foundation model, emphasizes a scalable, PACS-agnostic integration into existing radiology infrastructure, analyzing over 60 million patient cases annually across nearly 2,000 hospitals. Aidoc's strength is its breadth of detection and its vision for a unified AI layer that not only triages acute cases but also supports population health tools for incidental findings and provides analytics for radiology operations. It's best suited for health systems seeking a versatile, enterprise-wide AI solution to enhance overall radiology efficiency and expand their AI capabilities across a broader spectrum of conditions and workflows.
Key differentiators include Viz.ai's deep focus on acute care coordination with proven DIDO time reductions and a unique reimbursement advantage, versus Aidoc's extensive FDA clearance portfolio, foundation model approach, and broader applicability as a radiology triage and enterprise AI platform.
Frequently Asked Questions
QWhat types of medical conditions do Viz.ai and Aidoc primarily detect?
Viz.ai primarily focuses on time-sensitive conditions such as large vessel occlusion (LVO) stroke, pulmonary embolism (PE), and aortic disease, including aortic dissection and abdominal aortic aneurysm (AAA). Aidoc offers a broader portfolio, detecting these conditions along with vertebral fractures, intracranial hemorrhage, incidental pulmonary nodules, and cardiac conditions across various imaging modalities.
QHow do these AI platforms integrate with existing hospital systems?
Both Viz.ai and Aidoc are designed for seamless integration into existing hospital IT infrastructure. They connect with Picture Archiving and Communication Systems (PACS), Electronic Health Records (EHR), and other workflow systems. Aidoc specifically highlights its PACS-agnostic integration via HL7/FHIR, while Viz.ai emphasizes its real-time analysis upon scan acquisition and mobile app-based care team alerts.
QAre Viz.ai and Aidoc's AI algorithms FDA-cleared?
Yes, both Viz.ai and Aidoc are leaders in medical AI with numerous FDA-cleared algorithms. Viz.ai has 12 FDA-cleared algorithms, and Aidoc boasts one of the broadest portfolios of FDA clearances in the medical AI space, ensuring clinical safety and efficacy.
QWhat are the pricing models for Viz.ai and Aidoc?
Both Viz.ai and Aidoc operate on custom enterprise contracts with hospitals and health systems. There is no public or self-serve pricing available. Pricing is negotiated based on factors such as hospital size, imaging volume, the number of conditions/algorithms deployed, and integration complexity. Viz.ai notably has a Medicare NTAP designation, providing additional reimbursement for qualifying patient encounters.
QWhich platform is more widely adopted globally?
Aidoc is currently deployed in nearly 2,000 hospitals worldwide, analyzing over 60 million patient cases annually, making it one of the most widely adopted clinical AI platforms globally. Viz.ai is deployed in over 1,000 hospitals across the U.S. and Europe.
Popular Comparisons
Direct feature matrices, pricing breakdowns, and real-world benchmark duels
